Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Todd Bazemore

Todd Bazemore is recorded as CFO, COO and CEO at KALA BIO, Inc. (KALA). KALA BIO, Inc. reported in an 8-K filed February 2, 2026 that Todd Bazemore resigned as Class II director, effective December 19, 2025. KALA BIO, Inc. reported in an 8-K filed October 20, 2025 that Todd Bazemore was terminated as President and Chief Executive Officer, effective October 19, 2025. KALA BIO, Inc. reported in an 8-K filed September 2, 2025 that Todd Bazemore was appointed Class II director, effective August 29, 2025. Equibles holds 5 filed executive changes naming Todd Bazemore; each is listed under recent activity with its source filing. The proxy statement of KALA BIO, Inc. reports total compensation of $3,476,972 for Todd Bazemore in fiscal 2025, including a base salary of $489,112. Disclosed compensation is on record for 5 fiscal years. Todd Bazemore has spoken on 8 earnings calls across 1 company, most recently for KALA BIO, Inc. on May 16, 2022.

“on December 19, 2025, each of (i) Marjan Farid, M.D. and Andrew I. Koven, who were Class I directors of the Company, (ii) Mark Iwicki and Todd Bazemore were Class II directors of the Company, and (iii) C. Daniel Meyers and Howard B. Rosen, who were Class III directors of the Company (collectively, the "Resigning Directors"), tendered their resignations as directors of the Company, effective immediately following the Annual Meeting and upon approval of the Issuance Proposal and the Share Increase Proposal”
KALA BIO, Inc. Form 8-K, filed February 2, 2026 · Read the filing
“On October 19, 2025, in connection with the Reduction, the Board terminated without cause the employment of Todd Bazemore, the Company's President and Chief Executive Officer, effective immediately.”
KALA BIO, Inc. Form 8-K, filed October 20, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at KALA BIO, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 KALA BIO, Inc. (KALA) $489,112 $3,476,972
2024 KALA BIO, Inc. (KALA) $535,600 $949,550
2023 KALA BIO, Inc. (KALA) $535,600 $2,943,656
2022 KALA BIO, Inc. (KALA) $515,000 $1,025,817
2021 KALA BIO, Inc. (KALA) $489,878 $1,343,356

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.